Financials
Income statement
| Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
|---|---|---|---|---|
| Total reported revenue | 13.6B | 12.8B | 12.7B | 12.0B |
| Cost of revenue | 4.5B | 4.1B | 4.1B | 4.3B |
| Gross profit | 9.1B | 8.7B | 8.6B | 7.7B |
| Operating expense | ||||
| Research & development | 2.6B | 2.3B | 1.9B | 1.9B |
| Selling general and admin | 912.7M | 922.1M | 808.0M | 859.9M |
| Other operating expenses | — | — | — | — |
| Operating income | 5.2B | 5.0B | 5.5B | 4.2B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 687.1M | 654.7M | 743.3M | 779.9M |
| Other income expense | 15.3M | -51.9M | -58.7M | -619.0M |
| Pretax income | 4.5B | 4.3B | 4.7B | 3.2B |
| Tax provision | 974.9M | 102.2M | -11.1M | -376.3M |
| Net income | 3.5B | 4.2B | 4.7B | 3.7B |
| Basic EPS | 0.9 | 1.1 | 1.2 | 0.9 |
| Diluted EPS | 0.9 | 1.0 | 1.1 | 0.9 |
| Basic average shares | 4.0B | 4.0B | 4.0B | 4.0B |
| Diluted average shares | 4.1B | 4.1B | 4.1B | 4.1B |
| EBITDA | 7.2B | 6.9B | 7.4B | 6.5B |
| Net income from continuing op. | 3.5B | 4.2B | 4.7B | 3.7B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |